Mark your calendars for Monday 4th November 2024, as BioNTech SE (NASDAQ: BNTX) will be revealing its third quarter financial results. This highly awaited announcement is scheduled to take place before market open, pave the way to review a period of expectation and anticipation.
According to financial analysts on Wall Street, the organization is likely to announce an estimated per share $1.59 loss for the quarter. Additionally, the company is anticipated to reveal a total revenue of $663.72 million during this period.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated total revenue of $2.91 billion. In addition, they anticipate the company to report loss of $2.8 per share for the fiscal year.
Examining the corresponding quarter from the previous year, the company's earnings report unveiled a income of $0.73 per share. This number was attributed to the company's total revenue, which settled at an impressive $974.49 million during the same period.
Additionally, The company will host a conference call with investors and analysts on 4th November 2024 at 08:00 AM eastern time to review the Q3 2024 financial results.
BioNTech SE (BNTX) shares traded as low as $109.58 and as high as $113.76 on a day volume of 940.70 thousand shares, closed Friday's regular trading session at $111.48, drop of 1.43 percent.